|
WO2018098223A1
|
|
Sealable tray system and methods of using same
|
|
US2017368105A1
|
|
Human tissue derived compositions and uses thereof
|
|
EP3474665A1
|
|
Viable lyophilized compositions derived from human tissues and methods of making the same
|
|
WO2017053701A1
|
|
Umbilical tissue compositions and methods of use
|
|
CA2980316A1
|
|
Compositions comprising meniscal tissues and uses thereof
|
|
US2016082155A1
|
|
Bone repair product and methods of use thereof
|
|
WO2015138935A1
|
|
Support and packaging for membranes
|
|
US2015010610A1
|
|
Immunocompatible amniotic membrane products
|
|
EP3139936A1
|
|
Immunocompatible amniotic membrane products
|
|
US2015010609A1
|
|
Immunocompatible chorionic membrane products
|
|
US2015010506A1
|
|
Therapeutic placental compositions, methods of making and methods of use
|
|
EP3139935A1
|
|
Therapeutic placental compositions, methods of making and methods of use
|
|
KR20160149292A
|
|
Immunocompatible chorionic membrane products
|
|
MX2015000463A
|
|
Methods of manufacturing cartilage products.
|
|
EP2624846A2
|
|
Nanoparticle-loaded cells
|
|
EP2536826A1
|
|
Therapeutic products comprising vitalized placental dispersions
|
|
CA2750649A1
|
|
Cobalamin taxane bioconjugates for treating eye disease
|
|
NZ602248A
|
|
Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions
|
|
CA2731503A1
|
|
Taxane compounds for treating eye disease
|
|
EP2262513A1
|
|
Use of mesenchymal stem cells for treating genetic diseases and disorders
|
